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Abstract
Breast imaging represents a relatively recent and promising field of application of quantitative diffusion-MRI techniques. In
view of the importance of guaranteeing and assessing its reliability in clinical as well as research settings, the aim of this
study was to specifically characterize how the main MR scanner system-related factors affect quantitative measurements in
diffusion-MRI of the breast. In particular, phantom acquisitions were performed on three 1.5 T MR scanner systems by
different manufacturers, all equipped with a dedicated multi-channel breast coil as well as acquisition sequences for
diffusion-MRI of the breast. We assessed the accuracy, inter-scan and inter-scanner reproducibility of the mean apparent
diffusion coefficient measured along the main orthogonal directions (,ADC.) as well as of diffusion-tensor imaging (DTI)-
derived mean diffusivity (MD) measurements. Additionally, we estimated spatial non-uniformity of ,ADC. (NU,ADC.) and
MD (NUMD) maps. We showed that the signal-to-noise ratio as well as overall calibration of high strength diffusion gradients
system in typical acquisition sequences for diffusion-MRI of the breast varied across MR scanner systems, introducing
systematic bias in the measurements of diffusion indices. While ,ADC. and MD values were not appreciably different from
each other, they substantially varied across MR scanner systems. The mean of the accuracies of measured ,ADC. and MD
was in the range [22.3%,11.9%], and the mean of the coefficients of variation for ,ADC. and MD measurements across MR
scanner systems was 6.8%. The coefficient of variation for repeated measurements of both ,ADC. and MD was , 1%,
while NU,ADC. and NUMD values were ,4%. Our results highlight that MR scanner system-related factors can substantially
affect quantitative diffusion-MRI of the breast. Therefore, a specific quality control program for assessing and monitoring the
performance of MR scanner systems for diffusion-MRI of the breast is highly recommended at every site, especially in
multicenter and longitudinal studies.
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Introduction
In magnetic resonance imaging (MRI), ‘‘diffusion’’ (i.e. the
random, thermally-induced displacements of water molecules over
time) [1] represents an extraordinarily sensitive contrast mecha-
nism, and the exquisite structural detail it affords has proven useful
in a vast number of clinical as well as research applications,
especially in neuroimaging [2]. Currently, diffusion-MRI is a
promising and potentially useful MRI technique for improving the
diagnostic accuracy of breast imaging without administering
contrast agents [3–8]. Indeed, previous studies have shown a
potential role of quantitative diffusion-MRI in differentiating
between benign and malignant breast lesions [9–12], with the
majority of malignant lesions showing reduced diffusion when
compared to benign lesions, and diffusion-MRI may aid in
identifying patients with low grade ductal carcinoma in situ (DCIS)
as compared to high grade DCIS, hence contributing to risk-
stratification in DCIS [13,14]. Some studies have revealed an
inverse correlation between the cellularity of breast cancer and
diffusion indices [15,16], and diffusion indices have been seen to
vary significantly according to various histopathological and
immunohistochemical tumour features [17]. In locally advanced
breast cancer, another potential application of diffusion-MRI is in
the evaluation and assessment of the early response of cancer to
neoadjuvant chemotherapy [18–20]. Previous studies [21,22] have
reported a detectable increase of diffusion which manifested itself
before quantifiable decrease in tumour size, and the diffusion
change was observed as early as right upon completion of the first
cycle of neoadjuvant chemotherapy. Moreover, preliminary
studies have suggested that diffusion may be used as a biomarker
for pre-treatment prediction of response to neoadjuvant chemo-
therapy in patients with locally advanced breast cancer [5,23],
although this hypothesis needs further validation [24]. Diffusion-
MRI has also shown potential for evaluating residual breast cancer
following neoadjuvant chemotherapy [25].
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influence the accuracy and precision of quantitative diffusion-MRI
measurements [26–31]. In particular, it should be noted that the
signal-to-noise ratio (SNR) as well as the overall degree of
calibration of the high strength diffusion gradients system (which
are intrinsically linked to all stages of the diffusion-MRI pipeline,
from sequence design through data analysis) can directly and
systematically bias the measurement of diffusion indices [32].
Accordingly, some studies have emphasized the importance of
implementing specific diffusion-MRI related quality control
protocols as well as correction methods [33–44], which should
be put into practice in addition to standard quality assurance
routines in order to guarantee the reliability of quantitative
diffusion-MRI measurements. Furthermore, in diffusion-MRI
studies, a time- and site-dependency of MR scanner system
performance can introduce bias in diffusion-MRI measurements,
increase the variance of measured diffusion indices and substan-
tially reduce the power of statistical inference for detecting group
differences [30]. In this context, a number of in vivo studies have
analyzed intra-scanner variability of diffusion-MRI measurements
of the brain [27,28,45–53]. Moreover, given that the integration of
multicenter data would greatly improve the sensitivity of diffusion-
MRI studies, recent clinical investigations have specifically
evaluated the inter-scanner reproducibility of measurements of
different diffusion-tensor imaging (DTI)-derived indices in the
human brain [54–60]. In diffusion-MRI of the body, some in vivo
studies have evaluated the inter-scan reproducibility of measure-
ments of diffusion indices of the abdomen [61–64], liver [65–67],
prostate [68], anal canal [69] and kidney [70]. However, so far,
only a few clinical studies [71–74] have specifically investigated the
reliability of diffusion-MRI measurements in the breast in terms of
inter-scan reproducibility as well as intra- and inter-observer
reproducibility.
In view of the fact that breast imaging represents a relatively
recent field of application of quantitative diffusion-MRI tech-
niques, and based on the importance of guaranteeing and assessing
its reliability in clinical as well as research investigations, the aim of
this study was to specifically characterize how the main MR
scanner system-related factors affect quantitative measurements in
diffusion-MRI of the breast. In particular, we evaluated the
accuracy, inter-scan and inter-scanner reproducibility of measure-
ments of phantom diffusion indices performed on 1.5 T MR
scanner systems by different manufacturers, all equipped with a
dedicated multi-channel breast coil as well as acquisition
sequences for diffusion-MRI of the breast.
Materials and Methods
2.1. MR scanner systems and phantom
All diffusion-MRI acquisitions were performed on three
commercial 1.5 T MR scanner systems by three different
manufacturers, operating in three distinct centers: scanner-A
[GE Signa HDx TwinSpeed (GE Medical Systems - Milwaukee,
WI, USA) with 50 mT/m maximum gradient strength and
150 T/m/s slew rate], scanner-B [Philips Achieva (Philips
Medical Systems - Eindhoven, the Nederlands) with 66 mT/m
maximum gradient strength and 90 T/m/s slew rate] and
scanner-C [Siemens Avanto (Siemens Healthcare - Erlangen,
Germany) with 45 mT/m maximum gradient strength and
200 T/m/s slew rate]. All MR scanner systems were equipped
with a dedicated multi-channel breast coil with 8, 7 and 4 elements
for scanner-A, scanner-B and scanner-C, respectively. For each
MR scanner system, standard maintenance and quality assurance
procedures were routinely performed.
The same doped (per 1000 g H2O distilled: 1.25 g NiSO4 6
6H2O + 5 g NaCl) isotropic water phantom (i.e. two identical
cylindrical bottles with diameter 11.5 cm and length 20 cm) was
employed in all acquisitions.
2.2. Data acquisition
Images from different MR scanner systems were obtained using
pulse sequences provided by the manufacturers. For diffusion-
weighted image acquisition, we used a 2D axial spin echo - echo
planar imaging sequence, sensitized to diffusion (DWI-SE-EPI)
through strong magnetic field gradient pulses. The acquisition
protocols and parameters are reported in Table 1.
For each MR scanner system, all acquisitions were performed
on the same day in order to avoid any mid- and long-term changes
in scanner performance as well as any potential variability induced
by phantom repositioning. The phantom (i.e. two cylindrical
bottles as described above) was stored in the scanner room for at
least 24 hours prior to scanning and was positioned in the gantry
1 hour before acquisition. The centre of each of the two
cylindrical bottles was placed in the centre of each of the two
sides of the breast coil and secured using foam padding. The
central slice of the acquisition slab (21 slices) was placed at the
centre of the two bottles (Figure 1). The temperature of the
scanner bore was recorded during data acquisition.
2.2.1. SNR and calibration of diffusion gradients
system. In order to evaluate SNR as well as the calibration of
the high strength diffusion gradients system in each MR scanner,
the axial DWI-SE-EPI sequence (Table 1) was acquired both
without (b-value=0 s/mm
2) and with (b-value=850 s/mm
2) sensi-
tization to diffusion along each of the main orthogonal directions
(readout/left-right, phase-encoding/anterior-posterior, slice-selec-
tion/head-foot). In order to improve SNR, we employed a number
of excitations (NEX) equal to 14. The above acquisitions were
repeated obtaining a total of 5 measurements.
2.2.2. Accuracy, inter-scan and inter-scanner
reproducibility of diffusion-MRI measurements. In order
to assess the accuracy, inter-scan and inter-scanner reproducibility
of measurements of conventional mean apparent diffusion
Table 1. Axial 2D diffusion-weighted spin echo - echo planar
imaging (DWI-SE-EPI) sequence: acquisition parameters for
scanner-A, scanner-B and scanner-C.
Scanner-A Scanner-B Scanner-C
TR (ms) 8000 8000 8000
TE (ms) 81 81 83
BW (Hz/pixel) 3906 2905 2170
b-value (s/mm
2) 850 850 850
FOV (mm6mm) 3506350 3506350 3506350
Matrix 1286128 1286128 1286128
Slice thickness (mm) 5 5 5
Interslice gap (mm) 0 0 0
Number of slices 21 21 21
K space sampling 5/8 5/8 5/8
Parallel imaging ASSET SENSE mSENSE
Acceleration factor 2 2 2
Phase encoding
direction
anterior/posterior anterior/posterior anterior/posterior
doi:10.1371/journal.pone.0086280.t001
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(,ADC.) as well as DTI-derived indices (which a few breast
studies have preliminarily incorporated in their scanning protocols
[72,73,75–77]) additional diffusion-weighted images along each of
the main orthogonal directions and DTI data sets were acquired
using the DWI-SE-EPI sequence (Table 1) with b-value=850 s/
mm
2. For each MR scanner system, DTI acquisitions of the DWI-
SE-EPI sequence with sensitization to diffusion along 6 non-
collinear and non-coplanar directions [72,75,76] were performed.
For ,ADC. as well as DTI measurements, an additional
acquisition of the DWI-SE-EPI sequence without sensitization to
diffusion (b-value=0 s/mm
2) was carried out. In order to
guarantee a constant acquisition time, the NEX value was 7 and
4 for ,ADC. and DTI data sets, respectively. The entire set of
acquisitions was repeated obtaining a total of 5 measurements for
both ,ADC. and DTI data.
2.3. Image processing and analysis
Except for diffusion tensor estimation, all processing and
analysis of diffusion-MRI data was performed using custom scripts
developed in MATLAB 7.1 (MathWorks, Natick, MA, USA).
In order to better evaluate inter-scanner variability of diffusion-
MRI measurements independently of temperature (Ta) during
data acquisition, ADC measured along each of the main
orthogonal directions, ,ADC. and DTI-derived mean diffusivity
(MD) values were normalized to a reference value corresponding
to a temperature of 22uC (at which the phantom diffusion
coefficient, D0, is equal to 2.1460.03610
23 mm
2/s) [78]. In
particular, for each MR scanner system, we used an analytical
equation derived by fitting experimental water diffusion coeffi-
cients measured at different temperature values with the Arrhenius
activation law to obtain the true phantom diffusion coefficient at
Ta (Da) [78]. Given that for an isotropic phantom the ratio (R)
between the value of a diffusion index measured at Ta and Da
depends exclusively on the ratios (Rb
i=1-n, n=1, 3 and 6 for ADC
measured along each of the main orthogonal directions, ,ADC.
and MD, respectively) between the nominal and the effective b-
value applied along the diffusion sensitized directions (which can
reasonably be considered independent of temperature), the
normalized values of diffusion indices were calculated as RD0.
All analyses were carried out in the central slice of the acquired
phantom volume, within a reference region of interest (ROIref)
that consisted of two rectangles (size 29641 voxels), each placed in
the centre of the image of the bottle on each of two sides of the
breast coil (Figure 1).
2.3.1. SNR and maps of ADC along each of the main
orthogonal directions. The SNR was calculated using non-
diffusion-weighted (b0) images. Conventional approaches to
evaluate SNR are based on the signal statistics in one or two
separate large regions of interest of a single image or the signal
statistics in a large region of interest of a difference image of two
repeated acquisitions [79,80]. In order to take into account spatial
variations in SNR (which can be substantial in acquisitions
performed using multi-channel coils and parallel imaging
techniques) [81], maps of SNR in small adjacent ROIs of 868
voxels (SNRROI) were computed as previously described [81,82]:
SNRROI~
meanr[ROI½meank~1{5(Sb0(r,k)) 
meanr[ROI½stddevk~1{5(Sb0(r,k) 
ð1Þ
where Sb0(r,k) is the signal of the voxel at position r within the
selected ROI for the kth repetition of the b0 image. The overall
SNR was computed as the mean value of SNRROI within ROIref.
For each repetition (k=1–5), ADC maps along each of the main
orthogonal directions [ADCi,k(r) - i=1, readout/left-right; i=2,
phase-encoding/anterior-posterior; i=3, slice-selection/head-
foot] were computed. For the ith direction, the mean, (ADCi)mean,
and standard deviation, (ADCi)SD, images across repetitions were
calculated. Then, the overall ADC along the ith diffusion
weighting direction (ADCi) was obtained as the average (AD-
Ci)mean within ROIref. Furthermore, the overall percent coefficient
of variation for repeated measurements of ADC along the ith
diffusion weighting direction was computed as follows:
CVADCi~meanr[ROIref
(ADCi)SD(r)
(ADCi)mean(r)

|100 (%) ð2Þ
The spatial non-uniformity levels of maps of ADC along each of
the main orthogonal directions were evaluated by adapting a
method proposed by Magnusson and Olsson [83]. The ADCi,k
maps were smoothed using a low-pass spatial filter with a 363
kernel which reduces noise by computing the mean value of a
voxel and its 8 neighbours, and replacing the value of the voxel
with this mean. Then, the mean value (C) within ROIref was
estimated. For each voxel, the deviation from this value was
calculated as the absolute value of [1006(voxel value - C)/C],
obtaining a new image which represents the absolute value of the
percentage deviation from C. The mean value of this new image
within ROIref was recorded, obtaining the non-uniformity value of
ADCi,k maps (NUADCi,k) for each diffusion weighting direction
Figure 1. Schematic description of a) breast coil, phantom and acquisition slab (21 slices), as well as b) ROIref positioning.
doi:10.1371/journal.pone.0086280.g001
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weighting direction, the overall non-uniformity degree (NUADCi)
was estimated as the mean of NUADCi,k across repetitions.
2.3.2. Maps of ,ADC., MD and FA. For each repetition
(k=1–5), the mean ADC along the main orthogonal directions
[,ADC.k(r)] was calculated voxel-wise. The overall mean ADC
(,ADC.) and its coefficient of variation for repeated measure-
ments (CV,ADC.) were calculated as described above for ADCi
and CVADCi, respectively. Moreover, the overall spatial non-
uniformity degree of ,ADC. maps (NU,ADC.) was estimated
using the same method employed for calculating NUADCi.
In order to estimate the diffusion tensor, we adopted a method
similar to that described in previous breast DTI studies [72,76]. In
particular, we performed the standard steps implemented in the
diffusion toolbox (FDT) of FSL 4.1.4 (Oxford Centre for
Functional Magnetic Resonance Imaging of the Brain (FMRIB)
software library) [84,85] using the weighted linear least square
approach. For each repetition (k=1–5), the mean diffusivity
[MDk(r)] and fractional anisotropy [FAk(r)] were computed voxel-
wise. Then, the overall mean diffusivity (MD) and fractional
anisotropy (FA) were calculated as described for ADCi. The
coefficient of variation for repeated measurements of MD (CVMD)
and spatial non-uniformity of MD maps (NUMD) were then
obtained using the same procedure adopted for CVADCi and
NUADCicalculation.
2.3.3. Statistical analysis. Any significant difference in
quality control data and measured diffusion metrics, both across
the main orthogonal directions within a single MR scanner system
and across MR scanner systems, was assessed through a one-way
analysis of variance (ANOVA). When the ANOVA revealed a
significant difference (p,0.05), a post-hoc analysis was performed
using the two sample t-test, with Bonferroni correction for multiple
comparisons. For each MR scanner system, any significant
difference between ,ADC. and MD maps was assessed similarly.
The one-sample t-test, with Bonferroni correction for multiple
comparisons, was used to evaluate any significant difference
between the true diffusion indices and estimated diffusion indices.
Results
3.1. SNR and calibration of diffusion gradients system
The SNR (mean value 6 standard deviation within ROIref) was
242655, 184626 and 309660 for scanner-A, scanner-B and
scanner-C, respectively. The SNR values varied significantly
across MR scanner systems (ANOVA: p,0.0001 – post-hoc
analysis: p,0.001 for scanner-A vs scanner-B, scanner-A vs
scanner-C and scanner-B vs scanner-C).
For each of the main orthogonal directions (i=1–3), the ADCi,
CVADCi and NUADCi results are reported in Figure 2, Figure 3
and Figure 4, respectively. ADCi (i=1–3) values varied signifi-
cantly with diffusion gradient direction for scanner-A (ANOVA:
p,0.0001 – post-hoc analysis: p,0.001 for i=1vsi=2,i=1vs
i=3, i=2 vs i=3), scanner-B (ANOVA: p,0.0001 – post-hoc
analysis: p,0.001 for i=1vsi=2,i=1vsi=3,i=2vsi=3) and
scanner-C (ANOVA: p,0.0001 – post-hoc analysis: p,0.01 and
p,0.001 for i=1 vs i=2 and i=1 vs i=3, i=2 vs i=3,
respectively). Moreover, except for ADC1 for scanner-C (p.0.05),
all measured ADCi values were significantly (p,0.05) different
from the known phantom diffusion coefficient. For each MR
scanner system, CVADCi and NUADCi values varied significantly
with diffusion gradient direction (ANOVA: p,0.0001 – post-hoc
analysis: p,0.001 for i=1vsi=2,i=1vsi=3,i=2vsi=3).
3.2. Accuracy, inter-scan and inter-scanner reproducibility
of diffusion-MRI measurements
Both ,ADC. and MD data are reported in Figure 5. Within
each MR scanner system, ,ADC. and MD values were not
significantly different (p.0.05) from each other. On the other
hand, ,ADC. and MD values varied significantly across MR
scanner systems (ANOVA: p,0.0001 – post-hoc analysis:
p,0.001 for scanner-A vs scanner-B, scanner-A vs scanner-C
and scanner-B vs scanner-C). Both ,ADC. and MD values were
significantly (p,0.01) different from their true value, with an
Figure 2. Phantom ADC along each of the main orthogonal
directions (ADCi - i=1, readout/left-right; i=2, phase-encod-
ing/anterior-posterior; i=3, slice-selection/head-foot) for scan-
ner-A, scanner-B and scanner-C. The bar charts depict the mean of
the average value within ROIref 6 standard deviation across five
repetitions. The dashed line represents the known phantom diffusion
coefficient (2.1460.03610
23 mm
2/s) at the reference temperature
value of 22uC.
doi:10.1371/journal.pone.0086280.g002
Figure 3. Coefficient of variation for repeated measurements
of phantom ADC along each of the main orthogonal directions
(CVADCi - i=1, readout/left-right; i=2, phase-encoding/anteri-
or-posterior; i=3, slice-selection/head-foot) for scanner-A,
scanner-B and scanner-C. The bar charts depict the mean value 6
standard deviation within ROIref.
doi:10.1371/journal.pone.0086280.g003
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diffusion value) ranging from -2.6% to 12.0%.
The CV,ADC. and CVMD results as well as NU,ADC. and
NUMD results are reported in Table 2. For each MR scanner
system, CV,ADC. and CVMD differed significantly (p,0.001)
with values which were less than 1%. Moreover, CV,ADC. and
CVMD varied significantly across MR scanner systems (ANOVA:
p,0.0001 – post-hoc analysis: p,0.001 for scanner-A vs scanner-
B, scanner-A vs scanner-C and scanner-B vs scanner-C). For
scanner-A and scanner-B, NU,ADC. and NUMD were not
significantly (p.0.05) different, whereas, for scanner-C,
NU,ADC. was significantly (p,0.01) lower than NUMD. Further-
more, both NU,ADC. (ANOVA: p,0.0001 – post-hoc analysis:
p,0.001 and p.0.05 for scanner-A vs scanner-B, scanner-A vs
scanner-C and scanner-B vs scanner-C, respectively) and NUMD
(ANOVA: p,0.0001 – post-hoc analysis: p,0.001 for scanner-A
vs scanner-B, scanner-A vs scanner-C and scanner-B vs scanner-C)
varied significantly across MR scanner systems, with values which
were less than 4%.
For each MR scanner system, the overall FA of the phantom
was significantly (p,0.001) greater than 0. Moreover, FA values
varied significantly across MR scanner systems (ANOVA:
p,0.0001 – post-hoc analysis: p,0.001 for scanner-A vs
scanner-B, scanner-A vs scanner-C and scanner-B vs scanner-C).
In particular, FA values (mean of the average value within ROIref
6 standard deviation across five repetitions) were 0.08660.001,
0.05060.001 and 0.07660.001 for scanner-A, scanner-B and
scanner-C, respectively.
Discussion
A number of in vivo studies have evaluated the reliability of
diffusion-MRI measurements in the brain as well as body
[27,28,45–70,86]. However, a more specific and careful evaluation
of the reliability of diffusion-MRI measurements of the breast
would be of practical interest. Recently, O’Flynn et al. [71] have
assessed the mid-term reproducibility and inter-observer variabil-
ity of ADC measurements of fibroglandular tissue at 3 T,
obtaining a within-subject coefficient of variation of 22–25%
and a kappa value (k) of 0.83. Partridge et al. [72] have evaluated
the reproducibility of DTI-derived parameter measurements in
normal breast tissue at 1.5 T after repositioning and rescanning,
reporting a between-scan coefficient of variation of 4.5% and
11.4% for MD and FA, respectively. Tagliafico et al. [73] have
reported a between-scan coefficient of variation of 15% and 30%
for MD and FA measurements in normal breast tissue at 3 T,
respectively; moreover, when looking at intra-/inter-observer
variability, the k values were 0.82–0.89/0.73–0.83 and 0.60–
0.84/0.64–0.80 for MD and FA, respectively. Additionally, when
measuring ADC at 1.5 T in breast carcinomas, Petralia et al. [74]
estimated an intra- and inter-observer variability of 1.1% and 2%,
respectively. It should be noted that assessing and guaranteeing
reliability of quantitative diffusion-MRI measurements, which is a
prerequisite for successful clinical as well as research studies,
necessarily includes a characterization of the MR scanner system.
Indeed, although in vivo studies can evaluate repeatability and
reproducibility of diffusion-MRI measurements in a clinical setting
(which are fundamental elements toward carrying out longitudinal
as well as multicenter studies), such studies do not allow to address
measurement accuracy as well as some of the main characteristics
Figure 4. Non-uniformity of maps of phantom ADC along each
of the main orthogonal directions (NUADCi - i=1, readout/left-
right; i=2, phase-encoding/anterior-posterior; i=3, slice-selec-
tion/head-foot) for scanner-A, scanner-B and scanner-C. The bar
charts depict the mean value 6 standard deviation across five
repetitions.
doi:10.1371/journal.pone.0086280.g004
Figure 5. Mean ADC along the main orthogonal directions
(,ADC.) as well as mean diffusivity (MD) of the phantom for
scanner-A, scanner-B and scanner-C. The bar charts depict the
mean of the average value within ROIref 6 standard deviation across
five repetitions. The dashed line represents the known phantom
diffusion coefficient (2.1460.03610
23 mm
2/s) at the reference temper-
ature value of 22uC.
doi:10.1371/journal.pone.0086280.g005
Table 2. CV,ADC. and CVMD results [mean value (standard
deviation within ROIref)] as well as NU,ADC. and NUMD results
[mean value (standard deviation across five repetitions)] for
scanner-A, scanner-B and scanner-C.
Scanner-A Scanner-B Scanner-C
CV,ADC. (%) 0.69 (0.34) 0.64 (0.31) 0.81 (0.38)
CVMD (%) 0.53 (0.28) 0.67 (0.32) 0.92 (0.58)
NU,ADC. (%) 3.70 (0.04) 1.70 (0.08) 1.83 (0.14)
NUMD (%) 3.65 (0.09) 1.67 (0.08) 2.52 (0.09)
doi:10.1371/journal.pone.0086280.t002
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strength diffusion gradients system) that can systematically bias
quantitative diffusion-MRI measurements [30,32]. A limited
number of studies have reported phantom data specific to the
characterization of MR scanner systems for diffusion-MRI of the
brain as well as the body [34–41,43,57,58,87,88]. However, in
diffusion-MRI of the breast, only a few clinical studies have
incorporated a basic verification of the calibration of diffusion
gradients [11,22,72,89,90].
To the best of our knowledge, this is the first phantom study
which carries out multiple and specific quality controls in order to
characterize in detail different 1.5 T MR scanner systems by three
different manufacturers, all equipped with a dedicated multi-
channel breast coil as well as acquisition sequence for quantitative
diffusion-MRI of the breast. In particular, for each MR scanner
system, we evaluated the calibration of high strength diffusion
gradients for the three main orthogonal axes along which
diffusion-sensitizing gradients can be applied. Then, we assessed
how the MR scanner system-related factors affect the accuracy,
inter-scan and inter-scanner reproducibility of diffusion measure-
ments of ,ADC. as well as of DTI measurements of MD. We
used acquisition protocols and parameters typically employed in
diffusion-MRI of the breast, which, except for small differences in
readout bandwidth (BW) values, were similar for all MR scanner
systems. As suggested by Bogner et al. [89], we employed a b-value
of 850 s/mm
2. For all acquisitions, we used the same homoge-
neous and isotropic phantom with known diffusion coefficient,
allowing a proper evaluation of the accuracy of estimated diffusion
indices as well as non-uniformity of maps of diffusion indices. The
diffusion coefficient of the phantom at room temperature
(,2610
23 mm
2/s) is similar to water diffusion coefficient in
normal breast tissue (1.8–2.1610
23 mm
2/s), while it is slightly
higher than water diffusion coefficient in malign as well benign
breast tissue (0.9–1.7610
23 mm
2/s) [7,22,72,89,91]. In this
context, as previously described by Delakis et al. [35], the use of
a phantom with a relatively high diffusion coefficient is recom-
mended in order to improve the sensitivity to any discrepancies in
measured diffusion indices induced by differences between the
nominal and the effective b-value applied along the diffusion
sensitized directions.
Diffusion-MRI measurements are affected by an inherently low
SNR. In particular, both precision and accuracy of diffusion
indices can depend on SNR [27–29,82,92–94]. Therefore, we
began by characterizing each MR scanner system in terms of
SNR. In particular, the overall SNR of scanner-B was 24% and
40% lower than that of scanner-A and scanner-C, respectively.
Interestingly, based on the BW values of the acquisition protocols
(Table 1), scanner-A (highest BW value) was expected to show the
lowest SNR across MR scanner systems. Therefore, SNR results
cannot be ascribed to differences in BW values only, and are likely
to also reflect different overall sensitivities of the breast coils.
All MR scanner systems showed a high short term stability of
the performance of diffusion gradients. For each MR scanner
system, the overall coefficient of variation for repeated measure-
ments of ADC along each of the main orthogonal directions was
less than 1.1% (Figure 3). Nonetheless, for each MR scanner
system and direction (readout/left-right, phase-encoding/anterior-
posterior, slice-selection/head-foot) except for ADC measurements
along the readout/left-right direction for scanner-C, we revealed a
significant difference between the measured ADC and the true
diffusion coefficient. Moreover, for each MR scanner system, the
entity of this difference varied significantly with diffusion direction
(Figure 2). This effect, when quantified in terms of the coefficient
of variation of ADC measurements across the main orthogonal
directions, was more relevant for scanner-A (7.9%) as compared to
scanner-B (1.7%) and scanner-C (2.7%). As a whole, these results
indicate a mismatch between the theoretically assumed and the
effective b-value. This could originate from errors in diffusion
gradients amplitude, eddy current fields, concomitant field terms
and cross terms between diffusion gradients and imaging gradients
[2,32,87,88,95]. These factors are direction-dependent and can
have deleterious effects that are more prominent at the high
gradient strengths usually employed in diffusion-MRI [2,32]. In
addition, any diffusion gradient non-uniformity is expected to yield
a spatial variation in measured diffusion indices. For each MR
scanner system, we observed that the spatial non-uniformity values
of maps of ADC along each of the main orthogonal directions
depended significantly on the diffusion weighting direction.
Scanner-A showed a relatively high spatial non-uniformity value
(7.3%) of ADC along the phase-encoding/anterior-posterior
direction, while for both scanner-B and scanner-C the degree of
non-uniformity of ADC along each diffusion weighting direction
was less than 4.5% (Figure 4). In general, when DWI-SE-EPI
sequences (Table 1) are acquired, the high strength diffusion
gradients system belonging to each MR scanner system presented
an overall mis-calibration (not documented by standard mainte-
nance procedures and quality assurance routines), which can affect
diffusion indices measurement. Therefore, in order to improve the
reliability of quantitative diffusion-MRI of the breast, suitable
correction methods could be employed [34,36,37,40].
For each MR scanner system, the coefficient of variation for
short term repeated measurements of both ,ADC. and MD was
less than 1% (Table 2), while previous clinical studies [71–73]
which measured breast diffusion indices have reported a between-
scan coefficient of variation in the range 5–15%. The greater
experimental variability of in vivo diffusion-MRI measurements
when compared to our phantom study is likely due to patient
repositioning, manual ROI positioning and motion induced
effects.
For every MR scanner system, the spatial non-uniformities of
,ADC. and MD maps were less than 4% (Table 2). For scanner-
A and scanner-B, non-uniformities of ,ADC. and MD maps
were not significantly different. Conversely, for scanner-C, the
non-uniformity of the ,ADC. map (1.8%) was significantly
lower than the non-uniformity of the MD map (2.5%). For each
MR scanner system, we did not reveal any significant difference
between estimated ,ADC. and MD values, with an absolute
percentage difference between ,ADC. and MD of less than
0.6%. This indicates a correct pulse timing when using multiple
oblique diffusion gradients as employed in DTI, and may suggest
the negligibility of cross-term effects between diffusion and
imaging gradients along different directions [26,95,96]. However,
the accuracy of ,ADC. and MD measurements varied
significantly with the MR scanner system (Figure 5). In particular,
the mean value of ,ADC. and MD accuracies was 11.9%, 6.0%
and -2.3% for scanner-A, scanner-B and scanner-C, respectively,
while the mean value of the coefficients of variation for ,ADC.
and MD measurements across MR scanner systems was 6.8%.
Previous phantom studies of diffusion-MRI both using a head coil
[35,36,38–40,43,58,87] and a body coil [34,43] have reported
accuracy values of estimated diffusion indices ranging from 215%
to 30%. Other in vivo studies of the brain [45,46,54–59] have
reported a coefficient of variation in MD and FA across different
MR scanner systems in the ranges 4–15% and 5–29%, respec-
tively. In this context, it is important to note that the differences in
diffusion indices reported in previous clinical diffusion-MRI
studies of the breast range from 5% to 45% [9–13,17,21–
23,25,76]. Therefore, a comparison of breast diffusion-MRI data
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Moreover, during the planning of a multicenter study, the
accuracy of diffusion-MRI measurements should be carefully
assessed in every participating center. Additionally, in longitudinal
studies, a periodic monitoring of the accuracy of measured
diffusion indices is highly recommended. In a meta-analysis of 13
studies dealing with quantitative diffusion-MRI in the differential
diagnosis of breast lesions, Chen et al. [91] have shown that a) the
ADC values of benign lesions ranged from 1610
23 mm
2/s to
1.82610
23 mm
2/s, b) the cutoff values for differentiating malig-
nant from benign lesions ranged from 0.9610
23 mm
2/s to
1.76610
23 mm
2/s, and that c) the sensitivity and specificity
ranged from 63% to 100% and 46% to 97%, respectively. This
heterogeneity could be due to differences in patient characteristics
and diagnostic criteria, as well as to different diffusion-MRI
acquisition and analysis methods. However, we hypothesize that
potential differences in MR scanner system-related factors
between different MR scanner systems, which can systematically
bias accuracy and precision of diffusion-MRI measurements, may
contribute to explaining the results heterogeneity reported by
Chen et al. [91].
Besides DTI-based measurements of MD, we also performed
diffusion anisotropy estimation, and the overall FA value of the
isotropic phantom (true FA=0) was found to be significantly
greater than 0 for every MR scanner system. This could reflect
effects of relatively low SNR (high SNR has been shown to reduce
the brain anisotropy overestimation due to noise at a b-value
typically used in clinical DTI examinations, ,1000 s/mm
2)
[93,94], as well as errors in diffusion gradients amplitude (which
can result in mimicking anisotropy). While for each MR scanner
system FA values were less than 0.09, they were significantly
different among MR scanner systems. In particular, data acquired
on scanner-B resulted in the lowest FA estimate (,0.05).
Conclusions
Although breast imaging is an appealing and promising
application field of diffusion-MRI, only few in vivo studies have
recently evaluated the inter-scan reproducibility as well as intra-
and inter-observer reproducibility of diffusion measurements of
the breast [71–74]. In this phantom study, we characterized in
detail three 1.5 T MR scanner systems by three different
manufacturers, all equipped with a dedicated multi-channel breast
coil as well as acquisition sequences for quantitative diffusion-MRI
of the breast. The SNR as well as overall calibration of high
strength diffusion gradients system varied substantially across MR
scanner systems, introducing systematic bias in measurements of
diffusion indices. We note that in vivo diffusion-MRI measurements
of the breast can also depend on other non-MR scanner system-
related factors – such as subject-related artifacts (e.g. motion and
cardiac pulsation, physiological noise), perfusion and non-Gauss-
ian processes – that could further increase the variability in
diffusion measurements. Nonetheless, in order to improve the
reliability of quantitative breast diffusion-MRI and, hence, the
sensitivity of clinical studies, a specific and periodic quality control
program for characterizing and monitoring the performance of
breast coil and high strength diffusion gradients of MR scanner
system is highly recommended at every site, especially before
multicenter studies are tackled as well as during longitudinal
studies. In this context, we agree with Jones [30] and De Santis et
al. [41] who have recently emphasized that the quality control
culture in diffusion-MRI remains limited. Therefore, we feel that
in diffusion-MRI, which is a truly quantitative technique, enabling
a suitable and dedicated quality assurance program at every site
would represent a major step toward the effective use of every MR
scanner system as a ‘‘measurement tool’’, hence further improving
and strengthening the capabilities of this powerful diagnostic
modality.
Supporting Information
Figure S1 Maps of phantom ADC along each of the main
orthogonal directions (i=1, readout/left-right; i=2,
phase-encoding/anterior-posterior; i=3, slice-selec-
tion/head-foot), calculated using the first (k=1) of 5
repetitions (ADCi,1), for scanner-A (left pane), scanner-B
(middle pane) and scanner-C (right pane). In order to
facilitate visual assessment, the figure depicts a zoomed region
(located on one side of the breast coil) of the phantom containing
one of the two rectangular ROIs (highlighted in red) which make
up ROIref.
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